Kevin Kee Email

VP Pharmaceutical Development . Aerovate Therapeutics

Boston, MA

Location

k***@aerovatetx.com

Primary Email

Current Roles

Employees:
50
Revenue:
$5.6M
About
Aerovate Therapeutics is a biotechnology company focused on developing drugs that meaningfully improve the lives of patients with rare cardiopulmonary disease. Aerovate's lead program is a potentially disease modifying drug, AV-101, for people who suffer from pulmonary arterial hypertension (PAH).
Aerovate Therapeutics Address
Boston, MA 02116, US
Boston, MA
United States
Aerovate Therapeutics Email

Past Companies

Aerovate Therapeutics, Inc.VP of Pharmaceutical Development
Acorda Therapeutics, Inc.Executive Director of Analytical Development and Quality Control
Civitas TherapeuticsSenior Director of Analytical Development and Quality Control

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.